NYSE - Nasdaq Real Time Price USD

Regal Rexnord Corporation (RRX)

Compare
102.71
-18.80
(-15.47%)
At close: April 3 at 4:00:02 PM EDT
95.98
-6.73
(-6.55%)
Pre-Market: 8:38:13 AM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 1.46B
Earnings 41.2M

Q1'24

Q2'24

Q3'24

Q4'24

0
500M
1B
2B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

146.00
172.36 Average
102.71 Current
200.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 11111110
Avg. Estimate 1.832.419.6911.31
Low Estimate 1.792.268.910.14
High Estimate 1.892.581012
Year Ago EPS 22.299.129.69

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 10101010
Avg. Estimate 1.38B1.48B5.84B6.11B
Low Estimate 1.36B1.45B5.79B5.97B
High Estimate 1.4B1.5B5.88B6.29B
Year Ago Sales 1.55B1.55B6.03B5.84B
Sales Growth (year/est) -10.95%-4.67%-3.26%4.67%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 1.992.132.482.47
EPS Actual 22.292.492.34
Difference 0.010.160.01-0.13
Surprise % 0.52%7.40%0.44%-5.20%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 1.832.419.6911.31
7 Days Ago 1.832.419.7411.38
30 Days Ago 1.832.439.8811.46
60 Days Ago 2.22.6410.3311.97
90 Days Ago 2.252.6910.4812.24

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 1------
Up Last 30 Days --------
Down Last 7 Days --111
Down Last 30 Days 9111

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
RRX -8.64%5.17%6.28%16.72%
S&P 500 6.69%6.80%9.98%14.34%

Upgrades & Downgrades

Maintains Goldman Sachs: Buy to Buy 4/2/2025
Maintains Barclays: Overweight to Overweight 3/26/2025
Maintains Barclays: Overweight to Overweight 3/10/2025
Maintains Barclays: Overweight to Overweight 2/14/2025
Maintains Oppenheimer: Outperform to Outperform 2/7/2025
Maintains Citigroup: Buy to Buy 1/14/2025

Related Tickers